Zhu Xi-Wen, Gong Jian-Ping
Department of Hepatobiliary Surgery, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Asian Pac J Cancer Prev. 2013;14(3):1579-83. doi: 10.7314/apjcp.2013.14.3.1579.
Intercellular adhesion molecule-1 (ICAM-1) is a member of the immunoglobulin superfamily, its main function being to participate in recognition and adhesion between cells. ICAM-1 is considered closely related to occurrence, development, metastasis and invasion process of hepatocellular carcinoma (HCC). A variety of inflammatory cytokines and stimulus affect its expression through the nuclear factor-kappa B (NF-κB) signal transduction pathway. In the initial stage of inflammation, hepatocirrhosis and tumor development, ICAM-1 is expressed differently, and has varied effects on different cells to promote occurrence of malignancy and metastasis. ICAM-1 has diagnostic significance for AFP-negative or suspected HCC, and may be a prognositic significance. It is thus widely used in studies as a biomarker which reflects cancer cells metastasis as well as curative effect of drugs. Many new treatments of HCC may be based on the effects of ICAM-1 on different levels of function.
细胞间黏附分子-1(ICAM-1)是免疫球蛋白超家族的成员,其主要功能是参与细胞间的识别和黏附。ICAM-1被认为与肝细胞癌(HCC)的发生、发展、转移和侵袭过程密切相关。多种炎性细胞因子和刺激物通过核因子-κB(NF-κB)信号转导途径影响其表达。在炎症、肝硬化和肿瘤发展的初始阶段,ICAM-1的表达有所不同,并且对不同细胞具有不同作用,以促进恶性肿瘤的发生和转移。ICAM-1对甲胎蛋白阴性或疑似HCC具有诊断意义,并且可能具有预后意义。因此,它作为反映癌细胞转移以及药物疗效的生物标志物被广泛用于研究中。许多HCC的新治疗方法可能基于ICAM-1在不同功能水平上的作用。